Search

Your search keyword '"Tokarek, Tomasz"' showing total 273 results

Search Constraints

Start Over You searched for: Author "Tokarek, Tomasz" Remove constraint Author: "Tokarek, Tomasz"
273 results on '"Tokarek, Tomasz"'

Search Results

4. Angiographic and clinical outcome of SARS-CoV-2 positive patients with ST-segment elevation myocardial infarction undergoing primary angioplasty: A collaborative, individual patient data meta-analysis of six registry-based studies

7. Oral anticoagulation therapy in patients with atrial fibrillation at high risk of bleeding: Clinical characteristics and treatment strategies based on data from the Polish Multi-center Register of Atrial Fibrillation (POL-AF)

12. Niewłaściwe przepisywanie zredukowanej dawki NOAC w praktyce klinicznej — wyniki Polskiego Rejestru Migotania Przedsionków (POL-AF) u hospitalizowanych pacjentów

13. Neutrophil-activating Peptide 2 as a Novel Modulator of Fibrin Clot Properties in Patients with Atrial Fibrillation

14. Oral anticoagulation therapy in atrial fibrillation patients at high risk of bleeding: Clinical characteristics and treatment strategies based on data from the Polish multicenter register of atrial fibrillation (POL-AF).

16. Clinical outcomes in patients with acute myocardial infarction treated with primary percutaneous coronary intervention stratified according to duration of pain-to-balloon time and type of myocardial infarction.

19. A Study of Telemedical Applications Based on User Experience

20. Diabetes Mellitus Is Still a Strong Predictor of Periprocedural Outcomes of Primary Percutaneous Coronary Interventions in Patients Presenting with ST-Segment Elevation Myocardial Infarction (from the ORPKI Polish National Registry)

21. Do Patients with Atrial Fibrillation and a History of Ischemic Stroke Overuse Reduced Doses of NOACs?—Results of the Polish Atrial Fibrillation (POL-AF) Registry

24. Association of Hyperuricemia with Impaired Left Ventricular Systolic Function in Patients with Atrial Fibrillation and Preserved Kidney Function: Analysis of the POL-AF Registry Cohort

25. Inappropriate prescription of a reduced dosage of NOAC in clinical practice: the results of the Polish Atrial Fibrillation (POL-AF) Registry in hospitalized patients.

28. Czy wynik CHA2DS2-VASc determinuje leczenie przeciwzakrzepowe u pacjentów z migotaniem przedsionków? Dane z POLish Atrial Fibrillation (POL-AF) Registry?

30. Mid-regional pro-adrenomedullin and lactate dehydrogenase as predictors of left ventricular remodeling in patients with myocardial infarction treated with percutaneous coronary intervention

31. Why Did All Patients with Atrial Fibrillation and High Risk of Stroke Not Receive Oral Anticoagulants? Results of the Polish Atrial Fibrillation (POL-AF) Registry

34. Concomitant multi-vessel disease is associated with a lower procedural death rate in patients treated with percutaneous coronary interventions within the left main coronary artery (from the ORPKI registry)

35. Clinical outcomes in patients with acute myocardial infarction treated with primary percutaneous coronary intervention stratified according to duration of pain-to-balloon time and type of myocardial infarction

37. Does the CHA2DS2-VASc score determine anticoagulant treatment in atrial fibrillation patients? Data from the POLish Atrial Fibrillation (POL-AF) Registry

38. The usefulness of [$^{18}\textrm{F}$]F-fluorodeoxyglucose and [$^{18}\textrm{F}$]F-sodium fluoride positron emission tomography imaging in the assessment of early-stage aortic valve degeneration after transcatheter aortic valve implantation (TAVI) : protocol description and preliminary results

40. Hyperuricemia as a Marker of Reduced Left Ventricular Ejection Fraction in Patients with Atrial Fibrillation: Results of the POL-AF Registry Study

41. Characteristics and Treatment of Atrial Fibrillation with Respect to the Presence or Absence of Heart Failure. Insights from the Multicenter Polish Atrial Fibrillation (POL-AF) Registry

43. Symptomatic and Asymptomatic Patients in the Polish Atrial Fibrillation (POL-AF) Registry

45. Antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention, including compliance with current guidelines—data from the POLish Atrial Fibrillation (POL-AF) Registry

46. The Usefulness of [18F]F-Fluorodeoxyglucose and [18F]F-Sodium Fluoride Positron Emission Tomography Imaging in the Assessment of Early-Stage Aortic Valve Degeneration after Transcatheter Aortic Valve Implantation (TAVI)—Protocol Description and Preliminary Results

49. Clinical characteristics of patients based on the POL-AF registry compared to the registries of the pre - NOACs era. Do we still treat the same individuals?

Catalog

Books, media, physical & digital resources